Lupus Patients Risk Drug-Supplement Interactions

Nearly 30 percent of patients in a new study used supplement combinations that could interact with medications.

Updated on Oct. 6, 2026 in Arthritis

Gouache-painted editorial illustration of a glass vial and a small bowl of supplement pills on a neutral surface. — Nearly 30 percent of patients with lupus in a recent UCSF study take supplement combinations that may interact with their prescribed medications. AI Illustration. Upload story photo >

Live Poll

Do you routinely discuss your supplement use with your doctor to avoid potential medication interactions?

A study of 451 adults with systemic lupus erythematosus found that 29.5 percent take supplement-medication combinations that may pose interaction risks. The research highlights the high prevalence of supplement use among individuals managing the autoimmune condition.

Why it matters

Identifying potential interactions is crucial for patient safety, as many individuals with lupus use multiple supplements alongside their prescribed therapies. Understanding these usage patterns helps clinicians better manage treatment plans and mitigate risks of adverse effects.

Among the 451 study participants, 80.9 percent reported using at least one supplement, with 55.9 percent using two or more. Commonly used supplements included Vitamin D at 64.1 percent, multivitamins at 45.2 percent, and calcium at 29.7 percent.

The players

University of California San Francisco

This public research university serves as a major hub for medical research and the institutional base for the authors of the study.

The details

Researchers at the University of California San Francisco analyzed data from participants in the Approaches to Positive, Patient-centered Experiences of Aging with Lupus study. Investigators evaluated the potential for drug-supplement interactions by cross-referencing supplement usage rates, which also included Vitamin B12 and iron at 10.6 and 9.3 percent respectively.

The study was published online in Arthritis Care & Research on September 22, 2026.
HealthDay News reported on the findings on October 6, 2026.

Health Landscape

This study contributes to the ongoing monitoring of patient safety within the Approaches to Positive, Patient-centered Experiences of Aging with Lupus study. It highlights how integrating supplement use into clinical reviews is becoming a critical component of standard care for autoimmune disease management.

Patients taking supplements should maintain an updated list of all vitamins and products to share with their healthcare provider during appointments. Openly discussing these combinations can help clinicians adjust prescriptions to avoid potential interaction risks.

The takeaway

Patients managing chronic conditions like lupus should not assume supplements are benign even when they are commonly used. Regularly reviewing your entire intake of medications and vitamins with a specialist is the safest way to prevent dangerous interactions.